Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Day One Biopharmaceuticals, Inc. (DAWN)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 100,000,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Day One Biopharmaceuticals is a clinical-stage biopharmaceutical company. Co. is engaged in developing and commercializing targeted therapies for patients with genomically-defined cancers. Co.'s main product candidate, DAY101 (tovorafenib), is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor. Co.'s second product candidate, pimasertib, is an oral, highly-selective small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2 (MEK), a well-characterized key signaling node in the RAS/mitogen-activated protein kinase pathway.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 1,475,454
Total Buy Value $0 $0 $0 $14,978,328
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 3
Total Shares Sold 26,725 47,789 205,064 511,256
Total Sell Value $167,242 $419,230 $2,717,190 $7,668,432
Total People Sold 4 4 5 6
Total Sell Transactions 4 7 22 50
End Date 2025-03-30 2024-12-27 2024-06-28 2023-06-29

   
Records found: 225
  Page 1 of 9  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Bender Jeremy CHIEF EXECUTIVE OFFICER   •       •      –    2025-05-16 4 S $6.26 $87,385 D/D (13,964) 145,737     -
   Dubow Adam GENERAL COUNSEL   •       –      –    2025-05-16 4 S $6.26 $28,486 D/D (4,552) 47,136     -
   York Charles N Ii COO, CFO AND SECRETARY   •       –      –    2025-05-16 4 S $6.26 $26,796 D/D (4,282) 265,231     -
   Merendino Lauren Chief Commercial Officer   •       –      –    2025-05-16 4 S $6.26 $24,575 D/D (3,927) 35,161     -
   Bender Jeremy CHIEF EXECUTIVE OFFICER   •       •      –    2025-05-15 4 OE $0.00 $0 D/D 31,686 159,701     -
   Dubow Adam GENERAL COUNSEL   •       –      –    2025-05-15 4 OE $0.00 $0 D/D 12,086 51,688     -
   York Charles N Ii COO, CFO AND SECRETARY   •       –      –    2025-05-15 4 OE $0.00 $0 D/D 16,875 269,513     -
   Merendino Lauren Chief Commercial Officer   •       –      –    2025-05-15 4 OE $0.00 $0 D/D 10,536 39,088     -
   Merendino Lauren Chief Commercial Officer   •       –      –    2025-02-26 3 IO $0.00 $0 D/D 0 28,552     -
   Bender Jeremy CHIEF EXECUTIVE OFFICER   •       •      –    2025-02-18 4 S $11.96 $144,130 D/D (12,048) 128,015     -
   Dubow Adam GENERAL COUNSEL   •       –      –    2025-02-18 4 S $11.96 $55,580 D/D (4,646) 39,602     -
   York Charles N Ii COO, CFO AND SECRETARY   •       –      –    2025-02-18 4 S $11.96 $52,278 D/D (4,370) 252,638     -
   Bender Jeremy CHIEF EXECUTIVE OFFICER   •       •      –    2025-02-15 4 OE $0.00 $0 D/D 31,686 140,063     -
   Dubow Adam GENERAL COUNSEL   •       –      –    2025-02-15 4 OE $0.00 $0 D/D 12,086 44,248     -
   York Charles N Ii COO, CFO AND SECRETARY   •       –      –    2025-02-15 4 OE $0.00 $0 D/D 16,875 257,008     -
   Blackman Samuel C. HEAD OF R&D   •       –      –    2024-12-10 4 AS $13.31 $399,339 D/D (30,000) 1,034,015     -
   Dubow Adam GENERAL COUNSEL   •       –      –    2024-11-18 4 S $13.21 $41,810 D/D (3,165) 32,162     -
   York Charles N Ii COO, CFO AND SECRETARY   •       –      –    2024-11-18 4 S $13.21 $34,373 D/D (2,602) 240,133     -
   Bender Jeremy CHIEF EXECUTIVE OFFICER   •       •      –    2024-11-18 4 S $13.21 $139,420 D/D (10,554) 108,377     -
   Blackman Samuel C. HEAD OF R&D   •       –      –    2024-11-18 4 S $13.21 $29,142 D/D (2,206) 1,064,015     -
   Dubow Adam GENERAL COUNSEL   •       –      –    2024-11-15 4 OE $0.00 $0 D/D 8,399 35,327     -
   York Charles N Ii COO, CFO AND SECRETARY   •       –      –    2024-11-15 4 OE $0.00 $0 D/D 10,250 242,735     -
   Bender Jeremy CHIEF EXECUTIVE OFFICER   •       •      –    2024-11-15 4 OE $0.00 $0 D/D 19,999 118,931     -
   Blackman Samuel C. HEAD OF R&D   •       –      –    2024-11-15 4 OE $0.00 $0 D/D 8,686 1,066,221     -
   Blackman Samuel C. HEAD OF R&D   •       –      –    2024-11-11 4 AS $16.10 $160,994 D/D (10,000) 1,057,535     -
  225 Records found
  1  2  3  4  5  6  7  8  9   
  Page 1 of 9
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us